Concr predicts cancer treatment outcomes
Concr, a London-based techbio company, applies astrophysics methods to predict cancer treatment outcomes. Their platform, FarrSight®, enables accurate tumor modeling and clinical trial simulations, revolutionizing therapy prediction without relying on extensive data. With investors like University of Cambridge Enterprise and Oncology Ventures, Concr aims to reshape cancer treatment paradigms globally.
Visit website: https://concr.co/
AI can predict how early breast cancer patients might respond to their treatments
Durham University - 09-Feb-2024
This could lead to more personalised treatment plans and better outcomesRead more...